Successful management of cardiovascular diseases is crucial for preventing complications and improving patient outcomes. Learning about critical diagnostic assays plays a key role in this process. Diagnostic assays, such as those used to diagnose and assess the risk of cardiac diseases, provide valuable insights into a patient's condition. The HsTnI assay, for example, supports rapid decision-making by measuring high-sensitivity cardiac troponin I levels, aiding in the early detection of myocardial injury.
Keeping up with the most recent cardiac testing guidelines is crucial for faster and more accurate diagnosis. These guidelines outline the recommended tests, interpretation criteria, and algorithms for diagnosing various cardiac conditions. By following these guidelines, healthcare providers can ensure a standardized approach and make informed decisions to deliver optimal care for patients with cardiovascular diseases. The webinar below discusses the importance of the successful management of cardiovascular diseases. Viewers can learn about the critical diagnostic assays that diagnose and assess the risk of cardiac disease and understand how the HsTnI assay supports rapid decision-making. It also outlines the most recent cardiac testing guidelines and how they help faster and more accurate diagnosis of cardiac diseases.
Speakers
Dr. Amr Rouchdy, Professor of cardiothoracic surgery, Cairo University, Cairo University
Dr. Amr Amin, an Egyptian national, is a renowned cardiothoracic surgeon and professor at Cairo University. He holds a PhD in Cardiothoracic Surgery and has international fellowships from Hannover Medical School, University of Padova, and Cleveland Clinic. Currently, he heads the cardiothoracic surgery department at Sohag Heart Institute. His practice spans various private hospitals, with a focus on CABG operations, valve surgeries, and aortic aneurysms. His training in Germany, Italy, and the USA has honed his skills in complex aortic surgeries and minimally invasive mitral valve surgeries.
Dr. Heba Baz, Professor of Clinical Pathology, Cairo University
Dr. Heba Baz graduated from medical school in 1999. Her PhD was in biological and molecular markers of Polycystic Ovary Disease at Cairo University. In 2006, she received training at the University of Sherbrooke, Canada, regarding the use of biobanks in advancing research. Among her numerous publications, her work on reference intervals of routine chemistry analytes stands out. She has managed several private clinical laboratories and currently serves as a Professor of Clinical Pathology at Cairo University.
